News

Robles BioCeutics Welcomes Top-Ranked Regenerat...

News provided by Robles BioCeutics  Sep 02, 2025, 09:05 ET       Board-certified physician and regenerative medicine pioneer brings over 28 years of clinical experience in stem cell therapies to Robles...

Robles BioCeutics Signs Manufacturing Partnersh...

Regenerative Dermatology Company Advances Scalable Production of Senolytic-Enhanced Stem Cell Formulations Through Strategic Manufacturing Agreement SAN DIEGO, July 28, 2025 /PRNewswire/ -- Robles BioCeutics, a science-driven regenerative dermatology company developing skin-permeable senolytics and...

Robles BioCeutics Announces Anti-Aging Mechanis...

Landmark Study Reveals Essential Role of T Regulatory Cells in Reducing Skin Aging and Strengthens Intellectual Property Position SAN DIEGO, May 5, 2025 /PRNewswire/ -- Robles BioCeutics announced today presentation of peer-reviewed...

Robles BioCeutics Welcomes Experienced Drug Dev...

Accomplished Healthcare Entrepreneur to Help Guide Strategic Growth as Regenerative Dermatology Company Prepares for Clinical Trials SAN DIEGO, April 22, 2025 /PRNewswire/ -- Robles BioCeutics, a regenerative dermatology biotechnology company pioneering next-generation...

Robles BioCeutics Appoints Chief Financial Officer

Dr. Joseph Ellis to Drive Next Phase of Growth for Stem Cell Senolytics Biotechnology Company SAN DIEGO, March 4, 2025 /PRNewswire/ -- Robles BioCeutics, a regenerative dermatology biotechnology company focused on developing next-generation skin...

Robles BioCeutics Presents Glowselle™ Stem Cell...

Regenerative Dermatology Company Announces Synergy of TLR4 and TLR9 Stimulated Mesenchymal Stem Cells at Enhancing Collagen Production SAN FRANCISCO, Jan. 15, 2025 /PRNewswire/ -- Robles BioCeutics, a science-driven regenerative dermatology company focused on...